Reduce Antibiotic Usage

Antimicrobial stewardship is an organizational priority mandated by standards released from The Joint Commission and CMS to address growing concerns over antimicrobial resistance. With reimbursement and patient safety at stake, Sentri7 helps hospitals and health systems improve appropriate use of antibiotics, while arming clinicians with information to minimize drug costs, prevent harm, or avoid a potential medical situation.

Sentri7 helps hospitals quickly improve drug utilization and identify cost-saving opportunities to deliver tangible impacts on quality and expense. Care teams depend on Sentri7’s high-impact alerts to guide proper therapy, flag antimicrobial misuse, and identify opportunities to contain drug costs by proactively flagging drug substitutes.

Sentri7 supports the development of a robust antimicrobial stewardship program by ensuring regulatory compliance, reducing antimicrobial costs and improving patient care.

Sentri7 Rated Top Vendor to Drive Tangible Antimicrobial Stewardship Outcomes
-KLAS 2017 Antimicrobial Stewardship Report



5x increase in clinical interventions to improve appropriate use of antimicrobials


40% increase in antibiotic interventions


15% decrease in targeted broad-spectrum antibiotics representing cost savings of $1,621,730


3.9% reduction in days of therapy


Antimicrobial stewardship is only as successful as the program that supports a hospital’s efforts. Wolters Kluwer clinical experts help care teams develop robust programs based on a hospital’s current efforts and the actions required to align with the CDC core elements of an effective antimicrobial stewardship program. Learn more about Wolters Kluwer clinical services.

Antimicrobial Stewardship in Sentri7

Clinicians have a powerful arsenal of capabilities to monitor and control antimicrobial use including:

  • Antimicrobial agent selection – electronic rolling 12-month antibiogram
  • Redundant coverage notification
  • Drug-bug mismatches
  • Optimal drug dosing
  • Renal function surveillance
  • Prospective audit alerts for targeted and restricted drugs
  • Drug-to-drug interaction risks
  • Therapeutic substitutes or interchanges for cost control
  • Options to switch from one drug to an equally-effective, lower-cost alternative
  • IV-to-oral conversions

See how United Regional Healthcare uses Sentri7 to support their antimicrobial stewardship program.

Supporting the Workflow



Know the relevant goals and timelines for the National Action Strategy for Combating Antibiotic-Resistant Bacteria

Understand regulations, guidelines, penalties and preparation to build your antimicrobial stewardship program